Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
Funds three years replicating target engagement for a psychosocial intervention and testing whether that engagement tracks clinical change.
This notice sits at a precise point in the institute's pipeline: after a mechanism has been shown once, before anyone claims it explains the treatment's effect.
The interventions are psychosocial — therapeutic and preventive — for mental disorders. The stated purpose is speeding the translation of emerging research in basic, behavioural, cognitive, affective and neuropsychological science into in…
Up to three years replicating target engagement from prior studies for psychosocial therapeutic and preventive interventions for mental disorders, and testing the association between target engagement and change in clinical outcomes, translating emerging basic, behavioural, cognitive, affective and neuropsychological science into interventions. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults
🇺🇸NIH · United States
Funds a pilot trial of a behavioural sleep intervention for adolescents and young adults who have a mental health disorder or are at risk of one.
GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Similar grants
Browse the directory →
Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain
BRAIN Initiative · United States
Funds new methods to study brain cells and circuits with tools for deeper neural research.
Career Development and Transition Funding
Coefficient · United States
Supports professionals and students transitioning into global catastrophic risk careers.
Minor Use Minor Species Development of Drugs
FDA · United States
Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.
ADDF Drug Development RFP
ADDF · Global / Multinational
Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.
FARA Clinician Scientist Development Award
FARA · United States
Supports early-career clinician scientists with protected salary time to launch Friedreich's ataxia translational research careers.
Therapeutic Catalyst
CRUK · United Kingdom
Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.